RMIT sells toxicology testing business to vivoPharm
The addition of RDDT allows vivoPharm to expand its suite of toxicology testing services and make them available to its international as well as Australian customers. RDDT also brings a vast network of existing contacts and a strong client base.
RMIT, with support from the Victorian Government, established RDDT as a premier provider of toxicology services in Australia in 2004. Recently RMIT initiated an investigation, through independent adviser Bob Atwill, reviewing strategic options to take the business into international markets, and resulting in the identification of vivoPharm as a strong partner with suitable administration, infrastructure and international marketing activities.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.